Global Sulphonamides Market Growth 2020-2025
According to this study, over the next five years the Sulphonamides market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sulphonamides business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Sulphonamides market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Sulphonamides, covering the supply chain analysis, impact assessment to the Sulphonamides market size growth rate in several scenarios, and the measures to be undertaken by Sulphonamides companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Roche Holding AG
Boehringer Ingelheim Pharmaceuticals
GlaxoSmithKline
King Pharmaceuticals
Bayer AG
Pfizer
Mylan Pharmaceuticals
Par Pharmaceutical
Novartis International AG
Sanofi Aventis
Stiefel Laboratories
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Sulphonamides consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Sulphonamides market by identifying its various subsegments.
Focuses on the key global Sulphonamides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sulphonamides with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Sulphonamides submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sulphonamides Consumption 2015-2025
2.1.2 Sulphonamides Consumption CAGR by Region
2.2 Sulphonamides Segment by Type
2.2.1 Orally Absorbable Sulfonamide
2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
2.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
2.3 Sulphonamides Consumption by Type
2.3.1 Global Sulphonamides Consumption Market Share by Type (2015-2020)
2.3.2 Global Sulphonamides Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sulphonamides Sale Price by Type (2015-2020)
2.4 Sulphonamides Segment by Application
2.4.1 Skin Infections
2.4.2 Gastro Intestinal Tract (GIT) Infection
2.4.3 Meningitis
2.5 Sulphonamides Consumption by Application
2.5.1 Global Sulphonamides Consumption Market Share by Type (2015-2020)
2.5.2 Global Sulphonamides Value and Market Share by Type (2015-2020)
2.5.3 Global Sulphonamides Sale Price by Type (2015-2020)
3 Global Sulphonamides by Company
3.1 Global Sulphonamides Sales Market Share by Company
3.1.1 Global Sulphonamides Sales by Company (2018-2020)
3.1.2 Global Sulphonamides Sales Market Share by Company (2018-2020)
3.2 Global Sulphonamides Revenue Market Share by Company
3.2.1 Global Sulphonamides Revenue by Company (2018-2020)
3.2.2 Global Sulphonamides Revenue Market Share by Company (2018-2020)
3.3 Global Sulphonamides Sale Price by Company
3.4 Global Sulphonamides Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sulphonamides Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sulphonamides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Sulphonamides by Regions
4.1 Sulphonamides by Regions
4.2 Americas Sulphonamides Consumption Growth
4.3 APAC Sulphonamides Consumption Growth
4.4 Europe Sulphonamides Consumption Growth
4.5 Middle East & Africa Sulphonamides Consumption Growth
5 Americas
5.1 Americas Sulphonamides Consumption by Countries
5.1.1 Americas Sulphonamides Consumption by Countries (2015-2020)
5.1.2 Americas Sulphonamides Value by Countries (2015-2020)
5.2 Americas Sulphonamides Consumption by Type
5.3 Americas Sulphonamides Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Sulphonamides Consumption by Regions
6.1.1 APAC Sulphonamides Consumption by Regions (2015-2020)
6.1.2 APAC Sulphonamides Value by Regions (2015-2020)
6.2 APAC Sulphonamides Consumption by Type
6.3 APAC Sulphonamides Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Sulphonamides by Countries
7.1.1 Europe Sulphonamides Consumption by Countries (2015-2020)
7.1.2 Europe Sulphonamides Value by Countries (2015-2020)
7.2 Europe Sulphonamides Consumption by Type
7.3 Europe Sulphonamides Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Sulphonamides by Countries
8.1.1 Middle East & Africa Sulphonamides Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sulphonamides Value by Countries (2015-2020)
8.2 Middle East & Africa Sulphonamides Consumption by Type
8.3 Middle East & Africa Sulphonamides Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sulphonamides Distributors
10.3 Sulphonamides Customer
11 Global Sulphonamides Market Forecast
11.1 Global Sulphonamides Consumption Forecast (2021-2025)
11.2 Global Sulphonamides Forecast by Regions
11.2.1 Global Sulphonamides Forecast by Regions (2021-2025)
11.2.2 Global Sulphonamides Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sulphonamides Forecast by Type
11.8 Global Sulphonamides Forecast by Application
12 Key Players Analysis
12.1 Abbott Laboratories
12.1.1 Company Information
12.1.2 Sulphonamides Product Offered
12.1.3 Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Abbott Laboratories Latest Developments
12.2 Roche Holding AG
12.2.1 Company Information
12.2.2 Sulphonamides Product Offered
12.2.3 Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Roche Holding AG Latest Developments
12.3 Boehringer Ingelheim Pharmaceuticals
12.3.1 Company Information
12.3.2 Sulphonamides Product Offered
12.3.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
12.4 GlaxoSmithKline
12.4.1 Company Information
12.4.2 Sulphonamides Product Offered
12.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 GlaxoSmithKline Latest Developments
12.5 King Pharmaceuticals
12.5.1 Company Information
12.5.2 Sulphonamides Product Offered
12.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 King Pharmaceuticals Latest Developments
12.6 Bayer AG
12.6.1 Company Information
12.6.2 Sulphonamides Product Offered
12.6.3 Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer AG Latest Developments
12.7 Pfizer
12.7.1 Company Information
12.7.2 Sulphonamides Product Offered
12.7.3 Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 Mylan Pharmaceuticals
12.8.1 Company Information
12.8.2 Sulphonamides Product Offered
12.8.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Mylan Pharmaceuticals Latest Developments
12.9 Par Pharmaceutical
12.9.1 Company Information
12.9.2 Sulphonamides Product Offered
12.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Par Pharmaceutical Latest Developments
12.10 Novartis International AG
12.10.1 Company Information
12.10.2 Sulphonamides Product Offered
12.10.3 Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Novartis International AG Latest Developments
12.11 Sanofi Aventis
12.11.1 Company Information
12.11.2 Sulphonamides Product Offered
12.11.3 Sanofi Aventis Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sanofi Aventis Latest Developments
12.12 Stiefel Laboratories
12.12.1 Company Information
12.12.2 Sulphonamides Product Offered
12.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Stiefel Laboratories Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Sulphonamides Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Orally Absorbable Sulfonamide
Table 5. Major Players of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Table 6. Major Players of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Sulphonamides Consumption Market Share by Type (2015-2020)
Table 9. Global Sulphonamides Revenue by Type (2015-2020) ($ million)
Table 10. Global Sulphonamides Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Sulphonamides Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Sulphonamides Consumption Market Share by Application (2015-2020)
Table 14. Global Sulphonamides Value by Application (2015-2020)
Table 15. Global Sulphonamides Value Market Share by Application (2015-2020)
Table 16. Global Sulphonamides Sale Price by Application (2015-2020)
Table 17. Global Sulphonamides Sales by Company (2017-2019) (K MT)
Table 18. Global Sulphonamides Sales Market Share by Company (2017-2019)
Table 19. Global Sulphonamides Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Sulphonamides Revenue Market Share by Company (2017-2019)
Table 21. Global Sulphonamides Sale Price by Company (2017-2019)
Table 22. Global Sulphonamides Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Sulphonamides Products Offered
Table 24. Sulphonamides Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Sulphonamides Consumption by Regions 2015-2020 (K MT)
Table 26. Global Sulphonamides Consumption Market Share by Regions 2015-2020
Table 27. Global Sulphonamides Value by Regions 2015-2020 ($ Millions)
Table 28. Global Sulphonamides Value Market Share by Regions 2015-2020
Table 29. Americas Sulphonamides Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Sulphonamides Consumption Market Share by Countries (2015-2020)
Table 31. Americas Sulphonamides Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Sulphonamides Value Market Share by Countries (2015-2020)
Table 33. Americas Sulphonamides Consumption by Type (2015-2020) (K MT)
Table 34. Americas Sulphonamides Consumption Market Share by Type (2015-2020)
Table 35. Americas Sulphonamides Consumption by Application (2015-2020) (K MT)
Table 36. Americas Sulphonamides Consumption Market Share by Application (2015-2020)
Table 37. APAC Sulphonamides Consumption by Regions (2015-2020) (K MT)
Table 38. APAC Sulphonamides Consumption Market Share by Regions (2015-2020)
Table 39. APAC Sulphonamides Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Sulphonamides Value Market Share by Regions (2015-2020)
Table 41. APAC Sulphonamides Consumption by Type (2015-2020) (K MT)
Table 42. APAC Sulphonamides Consumption Market Share by Type (2015-2020)
Table 43. APAC Sulphonamides Consumption by Application (2015-2020) (K MT)
Table 44. APAC Sulphonamides Consumption Market Share by Application (2015-2020)
Table 45. Europe Sulphonamides Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Sulphonamides Consumption Market Share by Countries (2015-2020)
Table 47. Europe Sulphonamides Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Sulphonamides Value Market Share by Countries (2015-2020)
Table 49. Europe Sulphonamides Consumption by Type (2015-2020) (K MT)
Table 50. Europe Sulphonamides Consumption Market Share by Type (2015-2020)
Table 51. Europe Sulphonamides Consumption by Application (2015-2020) (K MT)
Table 52. Europe Sulphonamides Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Sulphonamides Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Sulphonamides Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Sulphonamides Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Sulphonamides Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Sulphonamides Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Sulphonamides Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Sulphonamides Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Sulphonamides Consumption Market Share by Application (2015-2020)
Table 61. Sulphonamides Distributors List
Table 62. Sulphonamides Customer List
Table 63. Global Sulphonamides Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Sulphonamides Consumption Market Forecast by Regions
Table 65. Global Sulphonamides Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Sulphonamides Value Market Share Forecast by Regions
Table 67. Global Sulphonamides Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Sulphonamides Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Sulphonamides Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Sulphonamides Value Market Share Forecast by Type (2021-2025)
Table 71. Global Sulphonamides Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Sulphonamides Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Sulphonamides Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Sulphonamides Value Market Share Forecast by Application (2021-2025)
Table 75. Abbott Laboratories Product Offered
Table 76. Abbott Laboratories Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Holding AG Product Offered
Table 81. Roche Holding AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. Roche Holding AG Main Business
Table 83. Roche Holding AG Latest Developments
Table 84. Roche Holding AG Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 85. Boehringer Ingelheim Pharmaceuticals Product Offered
Table 86. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Boehringer Ingelheim Pharmaceuticals Main Business
Table 88. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 89. Boehringer Ingelheim Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Product Offered
Table 91. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 95. King Pharmaceuticals Product Offered
Table 96. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. King Pharmaceuticals Main Business
Table 98. King Pharmaceuticals Latest Developments
Table 99. King Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer AG Product Offered
Table 101. Bayer AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. Bayer AG Main Business
Table 103. Bayer AG Latest Developments
Table 104. Bayer AG Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Product Offered
Table 106. Pfizer Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Pfizer Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. Mylan Pharmaceuticals Product Offered
Table 111. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Mylan Pharmaceuticals Main Business
Table 113. Mylan Pharmaceuticals Latest Developments
Table 114. Mylan Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 115. Par Pharmaceutical Product Offered
Table 116. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Par Pharmaceutical Main Business
Table 118. Par Pharmaceutical Latest Developments
Table 119. Par Pharmaceutical Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis International AG Product Offered
Table 121. Novartis International AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. Novartis International AG Main Business
Table 123. Novartis International AG Latest Developments
Table 124. Novartis International AG Basic Information, Company Total Revenue (in $ million), Sulphonamides Manufacturing Base, Sales Area and Its Competitors
Table 125. Sanofi Aventis Product Offered
Table 126. Sanofi Aventis Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. Sanofi Aventis Main Business
Table 128. Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Sanofi Aventis Latest Developments
Table 130. Stiefel Laboratories Product Offered
Table 131. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 132. Stiefel Laboratories Main Business
Table 133. Stiefel Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Stiefel Laboratories Latest Developments
List of Figures
Figure 1. Picture of Sulphonamides
Figure 2. Sulphonamides Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sulphonamides Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Sulphonamides Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Orally Absorbable Sulfonamide
Figure 7. Product Picture of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Figure 8. Product Picture of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Figure 9. Global Sulphonamides Consumption Market Share by Type (2015-2020)
Figure 10. Global Sulphonamides Value Market Share by Type (2015-2020)
Figure 11. Sulphonamides Consumed in Skin Infections
Figure 12. Global Sulphonamides Market: Skin Infections (2015-2020) (K MT)
Figure 13. Global Sulphonamides Market: Skin Infections (2015-2020) ($ Millions)
Figure 14. Sulphonamides Consumed in Gastro Intestinal Tract (GIT) Infection
Figure 15. Global Sulphonamides Market: Gastro Intestinal Tract (GIT) Infection (2015-2020) (K MT)
Figure 16. Global Sulphonamides Market: Gastro Intestinal Tract (GIT) Infection (2015-2020) ($ Millions)
Figure 17. Sulphonamides Consumed in Meningitis
Figure 18. Global Sulphonamides Market: Meningitis (2015-2020) (K MT)
Figure 19. Global Sulphonamides Market: Meningitis (2015-2020) ($ Millions)
Figure 20. Global Sulphonamides Consumption Market Share by Application (2015-2020)
Figure 21. Global Sulphonamides Value Market Share by Application (2015-2020)
Figure 22. Global Sulphonamides Sales Market Share by Company in 2017
Figure 23. Global Sulphonamides Sales Market Share by Company in 2019
Figure 24. Global Sulphonamides Revenue Market Share by Company in 2017
Figure 25. Global Sulphonamides Revenue Market Share by Company in 2019
Figure 26. Global Sulphonamides Sale Price by Company in 2019
Figure 27. Global Sulphonamides Consumption Market Share by Regions 2015-2020
Figure 28. Global Sulphonamides Value Market Share by Regions 2015-2020
Figure 29. Americas Sulphonamides Consumption 2015-2020 (K MT)
Figure 30. Americas Sulphonamides Value 2015-2020 ($ Millions)
Figure 31. APAC Sulphonamides Consumption 2015-2020 (K MT)
Figure 32. APAC Sulphonamides Value 2015-2020 ($ Millions)
Figure 33. Europe Sulphonamides Consumption 2015-2020 (K MT)
Figure 34. Europe Sulphonamides Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Sulphonamides Consumption 2015-2020 (K MT)
Figure 36. Middle East & Africa Sulphonamides Value 2015-2020 ($ Millions)
Figure 37. Americas Sulphonamides Consumption Market Share by Countries in 2019
Figure 38. Americas Sulphonamides Value Market Share by Countries in 2019
Figure 39. Americas Sulphonamides Consumption Market Share by Type in 2019
Figure 40. Americas Sulphonamides Consumption Market Share by Application in 2019
Figure 41. United States Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 42. United States Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 44. Canada Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 46. Mexico Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Sulphonamides Consumption Market Share by Countries in 2019
Figure 48. APAC Sulphonamides Value Market Share by Regions in 2019
Figure 49. APAC Sulphonamides Consumption Market Share by Type in 2019
Figure 50. APAC Sulphonamides Consumption Market Share by Application in 2019
Figure 51. China Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 52. China Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 54. Japan Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 56. Korea Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 58. Southeast Asia Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 59. India Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 60. India Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 62. Australia Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Sulphonamides Consumption Market Share by Countries in 2019
Figure 64. Europe Sulphonamides Value Market Share by Countries in 2019
Figure 65. Europe Sulphonamides Consumption Market Share by Type in 2019
Figure 66. Europe Sulphonamides Consumption Market Share by Application in 2019
Figure 67. Germany Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 68. Germany Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 69. France Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 70. France Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 71. UK Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 72. UK Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 74. Italy Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 76. Russia Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Sulphonamides Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Sulphonamides Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Sulphonamides Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Sulphonamides Consumption Market Share by Application in 2019
Figure 81. Egypt Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 82. Egypt Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 84. South Africa Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 86. Israel Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 88. Turkey Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Sulphonamides Consumption Growth 2015-2020 (K MT)
Figure 90. GCC Countries Sulphonamides Value Growth 2015-2020 ($ Millions)
Figure 91. Global Sulphonamides Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 92. Global Sulphonamides Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Sulphonamides Consumption 2021-2025 (K MT)
Figure 94. Americas Sulphonamides Value 2021-2025 ($ Millions)
Figure 95. APAC Sulphonamides Consumption 2021-2025 (K MT)
Figure 96. APAC Sulphonamides Value 2021-2025 ($ Millions)
Figure 97. Europe Sulphonamides Consumption 2021-2025 (K MT)
Figure 98. Europe Sulphonamides Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Sulphonamides Consumption 2021-2025 (K MT)
Figure 100. Middle East & Africa Sulphonamides Value 2021-2025 ($ Millions)
Figure 101. United States Sulphonamides Consumption 2021-2025 (K MT)
Figure 102. United States Sulphonamides Value 2021-2025 ($ Millions)
Figure 103. Canada Sulphonamides Consumption 2021-2025 (K MT)
Figure 104. Canada Sulphonamides Value 2021-2025 ($ Millions)
Figure 105. Mexico Sulphonamides Consumption 2021-2025 (K MT)
Figure 106. Mexico Sulphonamides Value 2021-2025 ($ Millions)
Figure 107. Brazil Sulphonamides Consumption 2021-2025 (K MT)
Figure 108. Brazil Sulphonamides Value 2021-2025 ($ Millions)
Figure 109. China Sulphonamides Consumption 2021-2025 (K MT)
Figure 110. China Sulphonamides Value 2021-2025 ($ Millions)
Figure 111. Japan Sulphonamides Consumption 2021-2025 (K MT)
Figure 112. Japan Sulphonamides Value 2021-2025 ($ Millions)
Figure 113. Korea Sulphonamides Consumption 2021-2025 (K MT)
Figure 114. Korea Sulphonamides Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Sulphonamides Consumption 2021-2025 (K MT)
Figure 116. Southeast Asia Sulphonamides Value 2021-2025 ($ Millions)
Figure 117. India Sulphonamides Consumption 2021-2025 (K MT)
Figure 118. India Sulphonamides Value 2021-2025 ($ Millions)
Figure 119. Australia Sulphonamides Consumption 2021-2025 (K MT)
Figure 120. Australia Sulphonamides Value 2021-2025 ($ Millions)
Figure 121. Germany Sulphonamides Consumption 2021-2025 (K MT)
Figure 122. Germany Sulphonamides Value 2021-2025 ($ Millions)
Figure 123. France Sulphonamides Consumption 2021-2025 (K MT)
Figure 124. France Sulphonamides Value 2021-2025 ($ Millions)
Figure 125. UK Sulphonamides Consumption 2021-2025 (K MT)
Figure 126. UK Sulphonamides Value 2021-2025 ($ Millions)
Figure 127. Italy Sulphonamides Consumption 2021-2025 (K MT)
Figure 128. Italy Sulphonamides Value 2021-2025 ($ Millions)
Figure 129. Russia Sulphonamides Consumption 2021-2025 (K MT)
Figure 130. Russia Sulphonamides Value 2021-2025 ($ Millions)
Figure 131. Spain Sulphonamides Consumption 2021-2025 (K MT)
Figure 132. Spain Sulphonamides Value 2021-2025 ($ Millions)
Figure 133. Egypt Sulphonamides Consumption 2021-2025 (K MT)
Figure 134. Egypt Sulphonamides Value 2021-2025 ($ Millions)
Figure 135. South Africa Sulphonamides Consumption 2021-2025 (K MT)
Figure 136. South Africa Sulphonamides Value 2021-2025 ($ Millions)
Figure 137. Israel Sulphonamides Consumption 2021-2025 (K MT)
Figure 138. Israel Sulphonamides Value 2021-2025 ($ Millions)
Figure 139. Turkey Sulphonamides Consumption 2021-2025 (K MT)
Figure 140. Turkey Sulphonamides Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Sulphonamides Consumption 2021-2025 (K MT)
Figure 142. GCC Countries Sulphonamides Value 2021-2025 ($ Millions)
Figure 143. Abbott Laboratories Sulphonamides Market Share (2018-2020)
Figure 144. Roche Holding AG Sulphonamides Market Share (2018-2020)
Figure 145. Boehringer Ingelheim Pharmaceuticals Sulphonamides Market Share (2018-2020)
Figure 146. GlaxoSmithKline Sulphonamides Market Share (2018-2020)
Figure 147. King Pharmaceuticals Sulphonamides Market Share (2018-2020)
Figure 148. Bayer AG Sulphonamides Market Share (2018-2020)
Figure 149. Pfizer Sulphonamides Market Share (2018-2020)
Figure 150. Mylan Pharmaceuticals Sulphonamides Market Share (2018-2020)
Figure 151. Par Pharmaceutical Sulphonamides Market Share (2018-2020)
Figure 152. Novartis International AG Sulphonamides Market Share (2018-2020)
Figure 153. Sanofi Aventis Sulphonamides Market Share (2018-2020)
Figure 154. Stiefel Laboratories Sulphonamides Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets